You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 91 No. 1, July 1965 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (42)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical Investigation of the Portacaval Shunt

I. Study Design and Preliminary Survival Analysis

FRANCIS C. JACKSON, MD; EDWARD B. PERRIN, JR., PhD; ANGELO E. DeGRADI, MD; ALBERT G. SMITH, MD; LYDON E. LEE, MD

AMA Arch Surg. 1965;91(1):43-54.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE ROLE of a portacaval shunt in the prevention of hemorrhage from esophagogastric varices and in the prolongation of life of patients with cirrhosis is unknown. Although two prospective studies1-4 have reported early survival analysis of this operation as a prophylaxis against hemorrhage and death from bleeding varices, there has been no controlled attempt to determine its effect upon the full spectrum of hepatic disease and the management of gastrointestinal hemorrhage.

Since Jan 1, 1962, investigators at 12 Veterans Administration hospitals have screened, classified, and randomized for therapy, patients admitted to their institutions and qualifying for the study under a uniform protocol. No patient was randomized until he was considered a satisfactory surgical risk and had agreed to accept an operation as a part of his treatment program. All patients were followed at regular intervals until death or lost to follow-up. . . . [Full Text PDF of this Article]


Author Affiliations

PITTSBURGH

From the departments of medicine and surgery, Veterans Administration. Associate Professor of Surgery, University of Pittsburgh, School of Medicine (Dr. Jackson); Associate Professor, Department of Preventive Medicine, University of Washington, School of Medicine (Dr. Perrin); Assistant Clinical Professor of Medicine, University of California, Los Angeles (Dr. DeGradi); Assistant Professor of Pathology, Duke University School of Medicine (Dr. Smith); Director, Surgical Service, Veterans Administration, departments of medicine and surgery (Dr. Lee).


Footnotes

Submitted for publication March 13, 1965.

Presented at the 22nd Annual Meeting of the Central Surgical Association, Milwaukee, March 4-6, 1965.

The opinions expressed represent those of the authors and do not reflect official policies of the Veterans Administration.

Reprint requests to Veterans Administration Hospital, Pittsburgh, Pa 15240 (Dr. Jackson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1965 American Medical Association. All Rights Reserved.